Literature DB >> 26409435

Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.

Mitchell Cheung1, Yuwaraj Kadariya1, Jacqueline Talarchek1, Jianming Pei1, Jill A Ohar2, Omar R Kayaleh3, Joseph R Testa4.   

Abstract

We report a high-risk cancer family with multiple mesotheliomas, cutaneous melanomas, basal cell carcinomas, and meningiomas segregating with a germline nonsense mutation in BAP1 (c.1938T>A; p.Y646X). Notably, most (four of five) mesotheliomas were peritoneal rather than the usually more common pleural form of the disease, and all five mesothelioma patients also developed second or third primary cancers, including two with meningiomas. Another family member developed both cutaneous melanoma and breast cancer. Two family members had basal cell carcinomas, and six others had melanocytic tumors, including four cutaneous melanomas, one uveal melanoma, and one benign melanocytic tumor. The family resides in a subtropical area, and several members had suspected exposure to asbestos either occupationally or in the home. We hypothesize that the concurrence of a genetic predisposing factor and environmental exposure to asbestos and UV irradiation contributed to the high incidence of multiple cancers seen in this family, specifically mesothelioma and various uveal/skin tumors, respectively.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Asbestos; BAP1; Cancer predisposition; Familial cancer; Malignant mesothelioma

Mesh:

Substances:

Year:  2015        PMID: 26409435      PMCID: PMC4634709          DOI: 10.1016/j.canlet.2015.09.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  29 in total

1.  Multiple primary cancers in families with Li-Fraumeni syndrome.

Authors:  M Hisada; J E Garber; C Y Fung; J F Fraumeni; F P Li
Journal:  J Natl Cancer Inst       Date:  1998-04-15       Impact factor: 13.506

2.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

3.  Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.

Authors:  Mohamed H Abdel-Rahman; Robert Pilarski; Colleen M Cebulla; James B Massengill; Benjamin N Christopher; Getachew Boru; Peter Hovland; Frederick H Davidorf
Journal:  J Med Genet       Date:  2011-09-22       Impact factor: 6.318

4.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

5.  Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008.

Authors:  S Jane Henley; Theodore C Larson; Manxia Wu; Vinicius C S Antao; Mary Lewis; Germania A Pinheiro; Christie Eheman
Journal:  Int J Occup Environ Health       Date:  2013 Jan-Mar

6.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

7.  A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.

Authors:  K A W Wadt; L G Aoude; P Johansson; A Solinas; A Pritchard; O Crainic; M T Andersen; J F Kiilgaard; S Heegaard; L Sunde; B Federspiel; J Madore; J F Thompson; S W McCarthy; A Goodwin; H Tsao; G Jönsson; K Busam; R Gupta; J M Trent; A-M Gerdes; K M Brown; R A Scolyer; N K Hayward
Journal:  Clin Genet       Date:  2014-11-06       Impact factor: 4.438

8.  Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

Authors:  Francis P Boscoe; Maria J Schymura
Journal:  BMC Cancer       Date:  2006-11-10       Impact factor: 4.430

9.  A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers.

Authors:  Lauren G Aoude; Karin Wadt; Anders Bojesen; Dorthe Crüger; Ake Borg; Jeffrey M Trent; Kevin M Brown; Anne-Marie Gerdes; Göran Jönsson; Nicholas K Hayward
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

Review 10.  Domestic asbestos exposure: a review of epidemiologic and exposure data.

Authors:  Emily Goswami; Valerie Craven; David L Dahlstrom; Dominik Alexander; Fionna Mowat
Journal:  Int J Environ Res Public Health       Date:  2013-10-31       Impact factor: 3.390

View more
  16 in total

Review 1.  Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Authors:  Sebastian Walpole; Antonia L Pritchard; Colleen M Cebulla; Robert Pilarski; Meredith Stautberg; Frederick H Davidorf; Arnaud de la Fouchardière; Odile Cabaret; Lisa Golmard; Dominique Stoppa-Lyonnet; Erin Garfield; Ching-Ni Njauw; Mitchell Cheung; Joni A Turunen; Pauliina Repo; Reetta-Stiina Järvinen; Remco van Doorn; Martine J Jager; Gregorius P M Luyten; Marina Marinkovic; Cindy Chau; Miriam Potrony; Veronica Höiom; Hildur Helgadottir; Lorenza Pastorino; William Bruno; Virginia Andreotti; Bruna Dalmasso; Giulia Ciccarese; Paola Queirolo; Luca Mastracci; Karin Wadt; Jens Folke Kiilgaard; Michael R Speicher; Natasha van Poppelen; Emine Kilic; Rana'a T Al-Jamal; Irma Dianzani; Marta Betti; Carsten Bergmann; Sandro Santagata; Sonika Dahiya; Saleem Taibjee; Jo Burke; Nicola Poplawski; Sally J O'Shea; Julia Newton-Bishop; Julian Adlard; David J Adams; Anne-Marie Lane; Ivana Kim; Sonja Klebe; Hilary Racher; J William Harbour; Michael L Nickerson; Rajmohan Murali; Jane M Palmer; Madeleine Howlie; Judith Symmons; Hayley Hamilton; Sunil Warrier; William Glasson; Peter Johansson; Carla Daniela Robles-Espinoza; Raul Ossio; Annelies de Klein; Susana Puig; Paola Ghiorzo; Maartje Nielsen; Tero T Kivelä; Hensin Tsao; Joseph R Testa; Pedram Gerami; Marc-Henri Stern; Brigitte Bressac-de Paillerets; Mohamed H Abdel-Rahman; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2018-12-01       Impact factor: 13.506

Review 2.  BAP1, a tumor suppressor gene driving malignant mesothelioma.

Authors:  Mitchell Cheung; Joseph R Testa
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  BAP1 mutations in high-grade meningioma: implications for patient care.

Authors:  Ganesh M Shankar; Sandro Santagata
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

4.  Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.

Authors:  Yuwaraj Kadariya; Mitchell Cheung; Jinfei Xu; Jianming Pei; Eleonora Sementino; Craig W Menges; Kathy Q Cai; Frank J Rauscher; Andres J Klein-Szanto; Joseph R Testa
Journal:  Cancer Res       Date:  2016-02-19       Impact factor: 12.701

Review 5.  Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.

Authors:  Alexandra M Haugh; Ching-Ni Njauw; Jeffrey A Bubley; Anna Elisa Verzì; Bin Zhang; Emily Kudalkar; Timothy VandenBoom; Kara Walton; Brian L Swick; Raj Kumar; Huma Q Rana; Sarah Cochrane; Shelley R McCormick; Christopher R Shea; Hensin Tsao; Pedram Gerami
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

6.  Molecular analysis of an asbestos-exposed Belgian family with a high prevalence of mesothelioma.

Authors:  Marieke Hylebos; Ken Op de Beeck; Jenneke van den Ende; Patrick Pauwels; Martin Lammens; Jan P van Meerbeeck; Guy Van Camp
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 7.  Roles of the BAP1 Tumor Suppressor in Cell Metabolism.

Authors:  Anna Han; Timothy J Purwin; Andrew E Aplin
Journal:  Cancer Res       Date:  2021-01-14       Impact factor: 13.312

Review 8.  Melanoma Risk and Melanocyte Biology.

Authors:  Julie U Bertrand; Eirikur Steingrimsson; Fanélie Jouenne; Brigitte Bressac-de Paillerets; Lionel Larue
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

9.  Case Report: Triple Primary Malignant Tumors of the Esophagus, Stomach, and Colon in a Patient With Genetic Analysis.

Authors:  Xiaoli Zhan; Lingzhe He; Kai Song; Shuliang Cao; Erhong Meng; Yuedong Wang
Journal:  Front Genet       Date:  2021-07-09       Impact factor: 4.599

Review 10.  Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.

Authors:  Michele Carbone; J William Harbour; James Brugarolas; Angela Bononi; Ian Pagano; Anwesha Dey; Thomas Krausz; Harvey I Pass; Haining Yang; Giovanni Gaudino
Journal:  Cancer Discov       Date:  2020-07-20       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.